Journal of Clinical Oncology

A phase 1b dose escalation study of FOR46, a novel antibody-drug conjugate targeting a tumor-specific epitope of CD46, in combination with enzalutamide (Enza) in patients with metastatic castration resistant prostate cancer (mCRPC).

Journal of Clinical Oncology

Nonna Shakhnazaryan, Nathan Curry, Medini Rastogi, Daniel Avins, Shrina Pandey, Ivan de Kouchkovsky, Daniel Kwon, Arpita Desai, Kelly N. Fitzgerald, Rohit Bose, Jonathan Chou, Terence W. Friedlander, Vadim S Koshkin, Lawrence Fong, Maya Aslam, Khadija Siddiqua, Eric J. Small, Bin Liu, Robert R. Flavell, Rahul Raj Aggarwal

Imaging of solid tumors using 68Ga-FAP-2286.

Journal of Clinical Oncology

Thomas A. Hope, Rahul Raj Aggarwal, Mallika Sachdev Dhawan, Robin Kate Kelley, Robert R. Flavell, Courtney Lawhn Heath, Yan Li, Sima P. Porten, Hope S. Rugo, Sue S. Yom, Robin Ippisch, Vadim S Koshkin

Impact of 68Ga-PSMA-11 PET on the management of biochemically recurrent prostate cancer in a prospective single-arm clinical trial.

Journal of Clinical Oncology

Wolfgang Fendler, Justin Ferdinandus, Jeremie Calais, Matthias Eiber, Robert R. Flavell, Ashley Mishoe, Felix Y Feng, Hao Gia Nguyen, Robert Evan Reiter, Matthew Rettig, Jeannine Gartmann, Raven Smith, Eric Jay Small, Roger Slavik, Peter Carroll, Ken Herrmann, Johannes Czernin, Thomas Hope